{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"213","value":"122"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Combination Group A: INCB053914 50 mg BID + Cytarabine","id":"OG000","title":"Parts 3 & 4: INCB053914 50 mg BID + Cytarabine"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 5","title":"Pharmacokinetics: Cl/F of Combination Treatment Group A INCB053914 50 mg + Cytarabine","type":"SECONDARY","unitOfMeasure":"L/hr"}